{"nctId":"NCT00330876","briefTitle":"Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","startDateStruct":{"date":"2006-06"},"conditions":["Hypercholesterolemia","Dyslipidemias"],"count":545,"armGroups":[{"label":"Pitavastatin 2 mg QD","type":"EXPERIMENTAL","interventionNames":["Drug: Pitavastatin"]},{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL","interventionNames":["Drug: Pitavastatin"]}],"interventions":[{"name":"Pitavastatin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Greater than or equal to 65 years of age\n* Primary hypercholesterolemia\n* Combined dyslipidemia\n* Completed study NK-104-306 (NCT00257686)\n\nExclusion Criteria:\n\n* Failed to complete study NK-104-306(NCT00257686)","healthyVolunteers":false,"sex":"ALL","minimumAge":"65 Years","stdAges":["OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in LDL-C","description":"percent change from baseline in low density lipoprotein-cholesterol (LDL-C)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.18","spread":"10.065"},{"groupId":"OG001","value":"-44.26","spread":"10.764"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Total Cholesterol","description":"Percent change from baseline in total cholesterol (TC)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-28.27","spread":"8.214"},{"groupId":"OG001","value":"-30.54","spread":"8.226"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":51,"n":449},"commonTop":["Nasopharyngitis","Myalgia","Hypertension","Arthralgia","Urinary tract infection"]}}}